8-K: Alphatec Holdings Mourns Passing of Board Member

Alphatec Holdings, Inc. announced with deep sadness the passing of Jeffrey P. Rydin, a long-serving and influential member of its Board of Directors.

Summary

• Alphatec Holdings, Inc. (ATEC) reported the passing of Jeffrey P. Rydin, a valued member of its Board of Directors, at age 59, following a lengthy illness.
• Mr. Rydin passed away on November 3, 2025, and the announcement was made via a press release on November 7, 2025.
• He had nearly three decades of experience in the medical device and healthcare industries, including senior sales leadership roles at Ellipse Technologies, Inc., NuVasive, Inc., and DePuy Spine, Inc.
• Mr. Rydin joined ATEC as a Special Advisor to the Board in September 2016, driving early decisions to transform the company's sales channel.
• He became a member of the ATEC Board in June 2017 and remained an informed, trusted voice until his passing.
• Pat Miles, Chairman and CEO, expressed profound sadness, acknowledging Rydin's significant contributions to ATEC's culture, momentum, early vision, and commitment.

Sentiment

Score: 4

Explanation: The sentiment is somber due to the passing of a key board member. While the company's tribute is positive, the event itself represents a loss of valuable expertise and leadership, which is a negative factor for the company's governance and strategic continuity.

Positives

• Jeffrey P. Rydin's extensive experience of nearly three decades in the medical device and healthcare industries, including senior sales leadership roles, significantly benefited ATEC.
• His early vision and commitment as a Special Advisor to the Board from September 2016 were instrumental in transforming ATEC's sales channel.
• As a Board member since June 2017, he provided an informed and trusted voice, contributing to the company's culture and momentum.

Negatives

• The passing of Jeffrey P. Rydin represents a significant loss of institutional knowledge and strategic guidance for Alphatec Holdings, Inc.
• The company loses a highly experienced board member who was deeply involved in its turnaround efforts and sales channel transformation.

Risks

• Loss of an experienced and influential board member could impact strategic decision-making and corporate governance.
• Potential disruption to board dynamics and the need for effective succession planning to fill the vacancy created by Mr. Rydin's passing.
• The company may face challenges in replacing the specific expertise and historical context Mr. Rydin brought to the board, particularly regarding sales channel strategy and medical device industry insights.

Future Outlook

NA

Management Comments

• "I am deeply saddened by this loss. Jeff has been a dear friend and colleague for decades."
• "The culture and momentum we have at ATEC today have been built, in no small part, on Jeff's early vision and commitment."
• "ATEC, and I personally, will be forever grateful to him for his unwavering dedication and service to our Company and its mission."
• "In life, if you're lucky, you come across a handful of people who just make the world better. Jeff was one of those people."
• "He was a measured but determined force; he was a trust-builder; he was someone you could always count on to deliver, even – and especially – when the odds were long."

Industry Context

The medical device and healthcare industries, particularly spine surgery, are highly specialized and benefit significantly from experienced leadership. The loss of a board member with nearly three decades of industry experience, like Mr. Rydin, can be a notable event for a company operating in this complex sector, potentially impacting strategic continuity and market insights.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: The loss of an experienced director could raise questions about the continuity of strategic guidance and oversight, potentially impacting investor confidence.
• Employees: The passing of a respected colleague and leader may affect morale within the company.
• Management: The executive team loses a trusted advisor and colleague, potentially requiring adjustments in strategic discussions and decision-making processes.

Next Steps

• The company will need to address the vacancy on its Board of Directors, which may involve identifying and appointing a new independent director with relevant industry experience.

Key Dates

Recommendation

The filing reports the unfortunate passing of a long-serving and influential board member. While this is a significant loss of institutional knowledge and strategic input, it does not immediately impact the company's operational or financial performance. Investors should hold to assess how the company manages the board vacancy and ensures continuity in its strategic direction, particularly given Mr. Rydin's historical contributions to sales channel transformation. This event warrants monitoring rather than an immediate change in investment stance based solely on this announcement.

Keywords

Alphatec Holdings, ATEC, Board of Directors, corporate governance, medical device, spine surgery, Jeffrey P. Rydin, personnel change